SynthesisESMO open2026

Neoadjuvant immune checkpoint inhibitors for localized dMMR/MSI-H gastric cancer: a meta-analysis.

W K Schwengber et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.